Ensysce Biosciences breakthrough in opioid innovation! FDA grants PF614-MPAR BTD for enhanced pain relief with overdose protection. Learn more about this cutting-edge drug.
Progress (NASDAQ:PRGS), the trusted provider of infrastructure software, today announced new powerful capabilities and enhancements in the latest release of Progress® Sitefinity®. Building on existing AI